General
Preferred name
OLEAMIDE
Synonyms
Oleic acid amide ()
Elaidoylamide ()
P&D ID
PD020526
CAS
301-02-0
181057-55-6
Tags
available
drug candidate
Drug indication
Discovery agent
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Oleamide is an endogenous fatty acid amide which can be synthesized de novo in the mammalian nervous system, and has been detected in human plasma.
DESCRIPTION Potentiator at 5-HT2A/2C receptors. Also CB1 agonist (Tocriscreen Total)
DESCRIPTION Selective inhibitor of NO-sensitive guanylyl cyclase (Tocris Bioactive Compound Library)
DESCRIPTION Oleamide (Oleic acid amide) is an endogenous fatty acid amide and can be used in the synthesis of de novo in the mammalian nervous system. (TargetMol Bioactive Compound Library)
Compound Sets
15
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
Drug Repurposing Hub
DrugMAP
EUbOPEN Chemogenomics Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Total
External IDs
43
Properties
(calculated by RDKit )
Molecular Weight
281.27
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
15
Ring Count
0
Aromatic Ring Count
0
cLogP
5.51
TPSA
43.09
Fraction CSP3
0.83
Chiral centers
0.0
Largest ring
0.0
QED
0.31
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Human Endogenous Metabolite
Endogenous Metabolite
HTR7, PLA2G2A
Primary Target
Other Lipid Metabolism
MOA
Cannabinoid Receptor agonist
Pathway
Metabolic Enzyme/Protease
Metabolism
Recommended Cell Concentration
None
Source data